Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 2941 AL 2955

The function of p53 and its role in Alzheimer's and Parkinson's disease compared to age-related macular degeneration

Wolfrum P, Fietz A, Schnichels S, Hurst J.

Front Neurosci. 2022 Dec 21;16:1029473. doi: 10.3389/fnins.2022.1029473. eCollection 2022.

Case report: (18)F-FES PET/CT predicted treatment responses of second-line and third-line CDK4/6 inhibitors after disease progression on first-line CDK4/6 inhibitor in a HR+/HER2- metastatic breast cancer patient

Pan B, Hao Z, Xu Y, Wang Z, Yao R, Wang X, Ren C, Zhou Y, Sun Q, Huo L.

Front Oncol. 2022 Dec 23;12:1095779. doi: 10.3389/fonc.2022.1095779. eCollection 2022.

Bipolar spectrum disorders in neurologic disorders

Digiovanni A, Ajdinaj P, Russo M, Sensi SL, Onofrj M, Thomas A.

Front Psychiatry. 2022 Dec 21;13:1046471. doi: 10.3389/fpsyt.2022.1046471. eCollection 2022.

Bioinformatics and systems biology approaches to identify the effects of COVID-19 on neurodegenerative diseases: A review

Bu F, Guan R, Wang W, Liu Z, Yin S, Zhao Y, Chai J.

Medicine (Baltimore). 2022 Dec 9;101(49):e32100. doi: 10.1097/MD.0000000000032100.

Gut-brain axis: Review on the association between Parkinson's disease and plant lectins

Moin K, Funk C, Josephs M, Coombes K, Yeakle M, Gala D, Ahmed-Khan M.

Arch Clin Cases. 2022 Dec 19;9(4):177-183. doi: 10.22551/2022.37.0904.10228. eCollection 2022.

Effectiveness of Nintendo Wii on Balance in People with Parkinson's Disease: A Systematic Review

Shahhar AZM, Qasheesh M, Shaphe MA.

J Lifestyle Med. 2022 Sep 30;12(3):105-112. doi: 10.15280/jlm.2022.12.3.105.

Therapeutic Potential of Active Components from Acorus gramineus and Acorus tatarinowii in Neurological Disorders and Their Application in Korean Medicine

Kim CJ, Kwak TY, Bae MH, Shin HK, Choi BT.

J Pharmacopuncture. 2022 Dec 31;25(4):326-343. doi: 10.3831/KPI.2022.25.4.326.

Targeting protein clearance pathways in GBA1-associated Parkinson disease

Chen C, Hertz E, Chen Y, Sidransky E.

Expert Opin Ther Targets. 2022 Dec;26(12):1031-1035. doi: 10.1080/14728222.2022.2166828. Epub 2023 Jan 12.

The safety and effectiveness of α-synuclein immunotherapy vs. placebo for the treatment of Parkinson's disease: a systematic review and meta-analysis

Hu F, Zhang S, Wang C, Zhou H, Shi H.

Ann Palliat Med. 2022 Dec;11(12):3764-3774. doi: 10.21037/apm-22-1356.

Predictive value of machine learning in diagnosing cognitive impairment in patients with Parkinson's disease: a systematic review and meta-analysis

Sun M, Yan T, Liu R, Zhao X, Zhou X, Ma Y, Jia J.

Ann Palliat Med. 2022 Dec;11(12):3775-3784. doi: 10.21037/apm-22-1396.

Camptocormia, a Rare Complication of Hemorrhagic Stroke: A Case Report

Ng KG, Teo QQ.

Cureus. 2022 Dec 12;14(12):e32450. doi: 10.7759/cureus.32450. eCollection 2022 Dec.

Depression and Parkinson's disease: a Chicken-Egg story

Chakraborty A, Diwan A.

AIMS Neurosci. 2022 Nov 23;9(4):479-490. doi: 10.3934/Neuroscience.2022027. eCollection 2022.

A Review of Commercial and Non-Commercial Wearables Devices for Monitoring Motor Impairments Caused by Neurodegenerative Diseases

Prieto-Avalos G, Sánchez-Morales LN, Alor-Hernández G, Sánchez-Cervantes JL.

Biosensors (Basel). 2022 Dec 31;13(1):72. doi: 10.3390/bios13010072.

Diagnosis and Treatment of Tremor in Parkinson's Disease Using Mechanical Devices

Fujikawa J, Morigaki R, Yamamoto N, Nakanishi H, Oda T, Izumi Y, Takagi Y.

Life (Basel). 2022 Dec 27;13(1):78. doi: 10.3390/life13010078.

Naringin and Naringenin Polyphenols in Neurological Diseases: Understandings from a Therapeutic Viewpoint

Emran TB, Islam F, Nath N, Sutradhar H, Das R, Mitra S, Alshahrani MM, Alhasaniah AH, Sharma R.

Life (Basel). 2022 Dec 29;13(1):99. doi: 10.3390/life13010099.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias